Japan implements three-stage plan for reimbursement cuts in April 2006 revision round
This article was originally published in Clinica
Japan's biannual reimbursement cuts, which are due to come into effect on April 1, include the unusual provision that they will be introduced over three phases (April 2006, January 2007 and April 2007).
You may also be interested in...
Thanks in part to budget authority bump, US FDA’s generic user fee revenue spending dropped in FY 2019, and hiring problems lead to an FTE decrease. The useable GDUFA carryover balance also increased in conjunction with the user fee revenue spending reduction, from $158.7m available at the end of FY 2018 to $199.2m at the end of FY 2019.
Distribution limits for Cialis prompts concerns among 340B-eligible providers that Lilly will impose similar restrictions for additional products and that other manufacturers may follow suit.
The agency is resuming domestic inspections using a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.